Join the Femara group to help and get support from people like you.
Femara News
Ribociclib + Nonsteroidal Aromatase Inhibitor Benefits Early Breast Cancer
THURSDAY, March 21, 2024 – Ribociclib plus a nonsteroidal aromatase inhibitor (NSAI) significantly improves invasive disease-free survival among patients with hormone receptor (HR)-positive, human...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Female Infertility, Breast Cancer - Adjuvant, Breast Cancer, Metastatic, Breast Cancer